01 1Uquifa Italia S.p.A. Agrate Brianza IT
01 1Carisoprodol - Monograph Text deleted 01/07/2020
01 1Spain
01 1Expired
Carisoprodol - Monograph Text Deleted 01/07/2020
Certificate Number : R0-CEP 2004-128 - Rev 00
Status : Expired
Issue Date : 2008-05-14
Type : Chemical
Substance Number : 1689
A Carisoprodol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carisoprodol, including repackagers and relabelers. The FDA regulates Carisoprodol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carisoprodol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carisoprodol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carisoprodol supplier is an individual or a company that provides Carisoprodol active pharmaceutical ingredient (API) or Carisoprodol finished formulations upon request. The Carisoprodol suppliers may include Carisoprodol API manufacturers, exporters, distributors and traders.
click here to find a list of Carisoprodol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carisoprodol CEP of the European Pharmacopoeia monograph is often referred to as a Carisoprodol Certificate of Suitability (COS). The purpose of a Carisoprodol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carisoprodol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carisoprodol to their clients by showing that a Carisoprodol CEP has been issued for it. The manufacturer submits a Carisoprodol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carisoprodol CEP holder for the record. Additionally, the data presented in the Carisoprodol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carisoprodol DMF.
A Carisoprodol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carisoprodol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carisoprodol suppliers with CEP (COS) on PharmaCompass.
LOOKING FOR A SUPPLIER?